D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 145,200
+2,700 (1.89%)
Aug 14, 2025, 2:40 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 1.57 trillion as of August 14, 2025. Its market cap has increased by 339.49% in one year.
Market Cap
1.57T
Enterprise Value
1.55T
Revenue
10.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
145,200.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 1.57T, an increase of 313.37%. That is a compound annual growth rate of 201.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 1,569.00B | 205.49% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 38.80T |
| ALTEOGEN | 23.35T |
| Yuhan | 8,487.38B |
| Peptron | 8,235.61B |
| SK Biopharmaceuticals | 7,878.31B |
| PharmaResearch | 6,909.12B |
| LigaChem Biosciences | 5,666.20B |